These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 23390922
1. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate. Özcan I, Azizoğlu E, Senyiğit T, Özyazici M, Özer Ö. J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922 [Abstract] [Full Text] [Related]
2. Enhanced dermal delivery of diflucortolone valerate using lecithin/chitosan nanoparticles: in-vitro and in-vivo evaluations. Özcan I, Azizoğlu E, Senyiğit T, Özyazıcı M, Özer Ö. Int J Nanomedicine; 2013 Jul; 8():461-75. PubMed ID: 23390364 [Abstract] [Full Text] [Related]
3. Effective topical delivery systems for corticosteroids: dermatological and histological evaluations. Eroğlu İ, Azizoğlu E, Özyazıcı M, Nenni M, Gürer Orhan H, Özbal S, Tekmen I, Ertam İ, Ünal İ, Özer Ö. Drug Deliv; 2016 Jun; 23(5):1502-13. PubMed ID: 25259424 [Abstract] [Full Text] [Related]
4. Nanoencapsulation of betamethasone valerate using high pressure homogenization-solvent evaporation technique: optimization of formulation and process parameters for efficient dermal targeting. Md S, Kuldeep Singh JKA, Waqas M, Pandey M, Choudhury H, Habib H, Hussain F, Hussain Z. Drug Dev Ind Pharm; 2019 Feb; 45(2):323-332. PubMed ID: 30404554 [Abstract] [Full Text] [Related]
5. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting. Pandey M, Choudhury H, Gunasegaran TAP, Nathan SS, Md S, Gorain B, Tripathy M, Hussain Z. Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170 [Abstract] [Full Text] [Related]
6. Lecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin. Senyiğit T, Sonvico F, Barbieri S, Ozer O, Santi P, Colombo P. J Control Release; 2010 Mar 19; 142(3):368-73. PubMed ID: 19932722 [Abstract] [Full Text] [Related]
7. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X, Sun M, Zheng A, Cao D, Bi Y, Sun J. Eur J Pharm Sci; 2012 Apr 11; 45(5):632-8. PubMed ID: 22248882 [Abstract] [Full Text] [Related]
8. In Vivo Assessment of Clobetasol Propionate-Loaded Lecithin-Chitosan Nanoparticles for Skin Delivery. Şenyiğit T, Sonvico F, Rossi A, Tekmen I, Santi P, Colombo P, Nicoli S, Özer Ö. Int J Mol Sci; 2016 Dec 26; 18(1):. PubMed ID: 28035957 [Abstract] [Full Text] [Related]
9. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P, Wang H, Yu M, Liao Z, Wang X, Zhang F, Ji W, Wu B, Han J, Zhang H, Wang H, Chang J, Niu R. Eur J Pharm Biopharm; 2012 Jun 26; 81(2):248-56. PubMed ID: 22446630 [Abstract] [Full Text] [Related]
10. Percutaneous permeation of betamethasone 17-valerate incorporated in lipid nanoparticles. Zhang J, Smith E. J Pharm Sci; 2011 Mar 26; 100(3):896-903. PubMed ID: 20839362 [Abstract] [Full Text] [Related]
11. Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery. Tan Q, Liu W, Guo C, Zhai G. Int J Nanomedicine; 2011 Mar 26; 6():1621-30. PubMed ID: 21904452 [Abstract] [Full Text] [Related]
12. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating. Jagani HV, Josyula VR, Palanimuthu VR, Hariharapura RC, Gang SS. Eur J Pharm Sci; 2013 Mar 12; 48(4-5):611-8. PubMed ID: 23291045 [Abstract] [Full Text] [Related]
13. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles. Malinovskaja-Gomez K, Labouta HI, Schneider M, Hirvonen J, Laaksonen T. Eur J Pharm Sci; 2016 Jun 30; 89():154-62. PubMed ID: 27131608 [Abstract] [Full Text] [Related]
14. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y, Xie XY, Mei XG. Drug Deliv; 2016 Jun 30; 23(3):787-93. PubMed ID: 24870204 [Abstract] [Full Text] [Related]
15. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency. Lee SY, Jung E, Park JH, Park JW, Shim CK, Kim DD, Yoon IS, Cho HJ. J Colloid Interface Sci; 2016 Oct 15; 480():102-108. PubMed ID: 27421112 [Abstract] [Full Text] [Related]
16. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP. Drug Deliv; 2010 Nov 15; 17(8):561-72. PubMed ID: 20738221 [Abstract] [Full Text] [Related]
17. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs. Takeuchi I, Takeshita T, Suzuki T, Makino K. Colloids Surf B Biointerfaces; 2017 Dec 01; 160():520-526. PubMed ID: 29017147 [Abstract] [Full Text] [Related]
18. Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles. Yang M, Yamamoto H, Kurashima H, Takeuchi H, Yokoyama T, Tsujimoto H, Kawashima Y. Eur J Pharm Sci; 2012 Aug 30; 47(1):235-43. PubMed ID: 22683651 [Abstract] [Full Text] [Related]
19. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP. Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228 [Abstract] [Full Text] [Related]
20. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Zeng P, Xu Y, Zeng C, Ren H, Peng M. Int J Pharm; 2011 Aug 30; 415(1-2):259-66. PubMed ID: 21645597 [Abstract] [Full Text] [Related] Page: [Next] [New Search]